Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 7/20 | 0.41 |
| ▸ | PPARA | Q07869 | 7/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.40 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.40 |
| ▸ | ALPI | P09923 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | XIAP | P98170 | 1/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
| ▸ | ALPL | P05186 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ALPG | P10696 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL27741433 | 0.92 | TSHR (0.41) | THRBTSHRTRPA1SRRCYP1A2 | |
| SCHEMBL26840962 | 0.85 | THRB (0.49) | THRBTSHRSRRCYP1A2PPARG | |
| SCHEMBL10061317 | 0.84 | THRB (0.49) | THRBTSHRADRB2ADRB1ADRB3 | |
| SCHEMBL6142338 | 0.84 | TSHR (0.42) | THRBTSHRADRB2ADRB1ADRB3 | |
| SCHEMBL8850716 | 0.84 | THRB (0.46) | THRBTSHRTRPA1PPARGPPARA | |
| SCHEMBL8191319 | 0.83 | CA1 (0.54) | THRBTSHRCYP1A2POLBHCAR2 | |
| SCHEMBL8481427 | 0.83 | TSHR (0.41) | THRBTSHRPPARGPPARAADRB2 | |
| SCHEMBL5467970 | 0.83 | TSHR (0.51) | THRBTSHRCYP1A2 | |
| SCHEMBL28354512 | 0.83 | THRB (0.46) | THRBTSHRSRRCYP1A2PPARG | |
| SCHEMBL8384744 | 0.82 | TSHR (0.40) | TSHRSRRPPARGPPARAADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106459316-A | Photocurable resin composition | 株式会社东进世美肯 | 2017-02-22 | — | — | CN | claimed |
| US-20250297146-A1 | WET AND DRY ADHESIVE SHAPE MEMORY ELASTOMERS | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2025-09-25 | — | — | US | disclosed |
| US-20240425631-A1 | LOW VISCOSITY URETHANE (METH)ACRYLATE MONOMERS AND THEIR USE IN PRODUCTION OF TOUGH POLYMERS WITH WELL-CONTROLLED MODULUS AND STRENGTH | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2024-12-26 | — | — | US | disclosed |
| EP-4426259-A1 | LOW VISCOSITY URETHANE (METH)ACRYLATE MONOMERS AND THEIR USE IN PRODUCTION OF TOUGH POLYMERS WITH WELL-CONTROLLED MODULUS AND STRENGTH | The Regents of the University of Colorado, a body corporate (US) | 2024-09-11 | — | — | EP | disclosed |
| CN-117980425-A | Active energy ray-curable adhesive sheet, adhesive sheet laminate with release film, laminate for image display device construction, image display device, and method for producing laminate for image display device construction | 三菱化学株式会社 | 2024-05-03 | — | — | CN | disclosed |
| WO-2023077159-A1 | LOW VISCOSITY URETHANE (METH)ACRYLATE MONOMERS AND THEIR USE IN PRODUCTION OF TOUGH POLYMERS WITH WELL-CONTROLLED MODULUS AND STRENGTH | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2023-05-04 | — | — | WO | disclosed |
| CN-115626997-A | Preparation method of polyurethane-based composite material | 四川东树新材料有限公司 | 2023-01-20 | — | — | CN | disclosed |
| CN-114230758-B | Polyurethane composition for wind power blade | 四川东树新材料有限公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-106459316-A | Photocurable resin composition | 株式会社东进世美肯 | 2017-02-22 | — | — | CN | disclosed |
| US-20150024215-A1 | SILVER-PLATED COATED BODY | MITSUBISHI PAPER MILLS LIMITED (JP) | 2015-01-22 | — | — | US | disclosed |
| US-7932340-B2 | Comprises self cleavage type radical-generating part and at least one unsaturated group in one molecule; suppresses volatilization of low molecular weight decomposition materials during radiation and post-baking, leaving no decomposition residues in final product; for use in printing inks, color filters | DAI NIPPON PRINTING CO., LTD. (JP) | 2011-04-26 | — | — | US | disclosed |
| US-20070037096-A1 | Comprises self cleavage type radical-generating part and at least one unsaturated group in one molecule; suppresses volatilization of low molecular weight decomposition materials during radiation and post-baking, leaving no decomposition residues in final product; for use in printing inks, color filters | DAI NIPPON PRINTING CO. LTD. | 2007-02-15 | — | — | US | disclosed |
| US-7141354-B2 | Photo radical generator, photo sensitive resin composition and article | DAI NIPPON PRINTING CO., LTD. (JP) | 2006-11-28 | — | — | US | disclosed |
| US-20050119433-A1 | Photo radical generator, photo sensitive resin composition and article | DAI NIPPON PRINTING CO., LTD. (JP) | 2005-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240425631-A1 | LOW VISCOSITY URETHANE (METH)ACRYLATE MONOMERS AND THEIR USE IN PRODUCTION OF TOUGH POLYMERS WITH WELL-CONTROLLED MODULUS AND STRENGTH | PUF60, ACR, UMPS | THRB 3904/4885TSHR 4677/4885TRPA1 3370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.